Licensed for intrathecal use
Products licensed for intrathecal use are the first line option and should be used wherever suitable.
There are no amikacin products licensed for intrathecal administration.
Not licensed for intrathecal use, limited information available
Products with partial information that are not licensed for intrathecal administration can still sometimes be used. Refer to the advice in our article and complete a risk assessment to enable you to interpret the details below and choose an appropriate product.
Hospira
Strength
Excipients
Sodium citrate, sodium metabisulfite (E223), water for injection
Osmolarity / osmolality
No information
pH
3.5 – 5.5
Endotoxin content
No information
Neon Healthcare
Strength
Excipients
Sodium metabisulfite (E223), sodium citrate, sulfuric acid, water for injection
Osmolarity / osmolality
No information
pH
5.0
Endotoxin content
≤0.33 IU/mg
Tillomed Laboratories
Strength
Excipients
Sodium metabisulfite (E223), sodium citrate dihydrate, sulfuric acid, water for injection
Osmolarity / osmolality
No information
pH
No information
Endotoxin content
No information
Vianex
Strength
Excipients
Sodium metabisulfite (E223), sodium citrate, sulfuric acid, water for injection
Osmolarity / osmolality
No information
pH
Release: 4.2-4.8
Shelf life: 3.5-5.5
Endotoxin content
≤0.33IU/mg
Hameln
Strength
Excipients
Sodium metabisulfite (E223), sodium citrate dihydrate, sulfuric acid, water for injection
Osmolarity / osmolality
No information
pH
3.5 – 5.5
Endotoxin content
≤0.25 EU/mg
Kent Pharmaceuticals
Strength
Excipients
Sodium metabisulfite (E223), sodium citrate, sulfuric acid, water for injection
Osmolarity / osmolality
No information
pH
No information
Endotoxin content
No information
Galvany Pharma
Strength
Excipients
Sodium metabisulfite (E223), Sodium citrate, water for injection
Osmolarity / osmolality
800 – 1100 mOsmol/kg
pH
3.5 – 5.5
Endotoxin content
≤3.3 IU/mL
Fresenius Kabi
Strength
5mg/mL in 50mL, 100mL or 200mL bottle
Excipients
Sodium chloride, hydrochloric acid, sodium hydroxide, water for injections
Osmolarity / osmolality
270 – 330 mOsmol/kg
pH
3.5 – 5.5
Endotoxin content
<0.83 EU/mL
Mercury
Strength
Excipients
Sodium metabisulfite (E223), sodium citrate dihydrate, sulfuric acid, water for injection
Osmolarity / osmolality
No information
pH
3.5 – 5.5
Endotoxin content
No information
Demo Pharmaceutical
Strength
Excipients
Sodium citrate dihydrate, sodium metabisulfite, sulfuric acid (2N), water for injections
Osmolarity / osmolality
No information
pH
3.5 – 5.5
Endotoxin content
≤3.3 EU/mL
Unlicensed ‘Special’, specified for intrathecal use
Unlicensed medicines that are manufactured in MHRA-licensed Specials Manufacturing Units, at the request of an authorised healthcare professional specifically for intrathecal use.
Royal Liverpool Hospitals NHS Foundation Trust
Amikacin intrathecal injection in sodium chloride 0.9%
Strength
25mg / 5mL
Update history
- Republished
- Full update to monograph
- Title and URL shortened.
- Published